Skip to Content

Label Changes for:

Trusopt (dorzolamide hydrochloride ophthalmic solution) 

October 2008

Changes have been made to the PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- October 2008


The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary. Read about the new physician labeling format.

Summary View


Sections Modified


  • General
    • The following text has been added:

“There is an increased potential for developing corneal edema in patientswith low endothelial cell counts. Precautions should be used when prescribing Trusopt to this group of patients.”